Edward Melanson
Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Energy Metabolism | 52 | 2024 | 831 | 7.260 |
Why?
| Exercise | 46 | 2025 | 1917 | 4.600 |
Why?
| Weight Loss | 25 | 2025 | 725 | 3.880 |
Why?
| Energy Intake | 29 | 2025 | 454 | 2.740 |
Why?
| Calorimetry, Indirect | 20 | 2024 | 80 | 2.170 |
Why?
| Fasting | 8 | 2025 | 264 | 2.000 |
Why?
| Thermogenesis | 6 | 2024 | 44 | 2.000 |
Why?
| Caloric Restriction | 6 | 2025 | 108 | 1.890 |
Why?
| Obesity | 27 | 2025 | 2859 | 1.880 |
Why?
| Calorimetry | 10 | 2024 | 64 | 1.610 |
Why?
| Adipose Tissue, Brown | 3 | 2024 | 51 | 1.500 |
Why?
| Sleep | 16 | 2024 | 675 | 1.390 |
Why?
| Breakfast | 2 | 2020 | 15 | 1.380 |
Why?
| Weight Reduction Programs | 5 | 2025 | 111 | 1.360 |
Why?
| Eating | 12 | 2022 | 368 | 1.320 |
Why?
| Meals | 5 | 2020 | 118 | 1.290 |
Why?
| Dietary Fats | 7 | 2019 | 301 | 1.290 |
Why?
| Overweight | 11 | 2025 | 522 | 1.220 |
Why?
| Resistance Training | 6 | 2024 | 151 | 1.100 |
Why?
| Accelerometry | 5 | 2025 | 91 | 1.080 |
Why?
| Oxygen Consumption | 13 | 2025 | 669 | 1.060 |
Why?
| Body Composition | 19 | 2025 | 644 | 1.000 |
Why?
| Circadian Rhythm | 13 | 2024 | 409 | 0.940 |
Why?
| Basal Metabolism | 8 | 2024 | 57 | 0.940 |
Why?
| Gonadotropin-Releasing Hormone | 4 | 2024 | 207 | 0.880 |
Why?
| Premenopause | 3 | 2020 | 121 | 0.870 |
Why?
| Behavior Therapy | 3 | 2021 | 236 | 0.860 |
Why?
| Estradiol | 2 | 2018 | 486 | 0.860 |
Why?
| Oxygen Isotopes | 5 | 2021 | 22 | 0.860 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2024 | 127 | 0.840 |
Why?
| Monitoring, Physiologic | 6 | 2024 | 264 | 0.840 |
Why?
| Diet | 8 | 2023 | 1198 | 0.830 |
Why?
| Lipid Metabolism | 5 | 2012 | 491 | 0.810 |
Why?
| Adult | 69 | 2025 | 35176 | 0.810 |
Why?
| Dietary Carbohydrates | 8 | 2019 | 150 | 0.790 |
Why?
| Dietary Proteins | 7 | 2019 | 128 | 0.760 |
Why?
| Water | 4 | 2024 | 439 | 0.760 |
Why?
| Humans | 117 | 2025 | 128019 | 0.760 |
Why?
| Body Weight | 11 | 2021 | 930 | 0.750 |
Why?
| Female | 82 | 2025 | 68016 | 0.740 |
Why?
| Sleep Deprivation | 9 | 2021 | 171 | 0.740 |
Why?
| Walking | 9 | 2025 | 494 | 0.740 |
Why?
| Ovary | 3 | 2020 | 210 | 0.710 |
Why?
| Body Mass Index | 20 | 2025 | 2260 | 0.690 |
Why?
| Cancer Survivors | 2 | 2022 | 263 | 0.680 |
Why?
| Estrogens | 2 | 2024 | 342 | 0.680 |
Why?
| Reference Standards | 1 | 2020 | 168 | 0.670 |
Why?
| Weight Gain | 10 | 2024 | 503 | 0.640 |
Why?
| Exercise Test | 10 | 2024 | 613 | 0.640 |
Why?
| Time Factors | 20 | 2021 | 6479 | 0.640 |
Why?
| Male | 79 | 2025 | 62757 | 0.630 |
Why?
| Middle Aged | 42 | 2025 | 30812 | 0.630 |
Why?
| Adipose Tissue, White | 1 | 2018 | 37 | 0.600 |
Why?
| Exercise Tolerance | 3 | 2025 | 271 | 0.600 |
Why?
| Pulmonary Gas Exchange | 2 | 2018 | 118 | 0.600 |
Why?
| Young Adult | 24 | 2025 | 12281 | 0.570 |
Why?
| Fats | 3 | 2009 | 14 | 0.570 |
Why?
| Physical Exertion | 5 | 2018 | 207 | 0.560 |
Why?
| Isotope Labeling | 1 | 2017 | 73 | 0.550 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 146 | 0.540 |
Why?
| Rest | 4 | 2018 | 120 | 0.500 |
Why?
| Leuprolide | 1 | 2015 | 19 | 0.490 |
Why?
| Muscle, Skeletal | 6 | 2014 | 1619 | 0.490 |
Why?
| Oxidation-Reduction | 11 | 2019 | 1001 | 0.480 |
Why?
| Cold Temperature | 3 | 2024 | 153 | 0.450 |
Why?
| Arthroplasty, Replacement, Knee | 3 | 2025 | 300 | 0.450 |
Why?
| Hunger | 2 | 2021 | 38 | 0.450 |
Why?
| Mass Spectrometry | 1 | 2017 | 662 | 0.450 |
Why?
| Autonomic Nervous System Diseases | 2 | 2025 | 34 | 0.450 |
Why?
| Cross-Over Studies | 9 | 2022 | 507 | 0.440 |
Why?
| Fatty Acids | 3 | 2012 | 415 | 0.410 |
Why?
| Breast Neoplasms | 2 | 2022 | 2131 | 0.410 |
Why?
| Parkinson Disease | 3 | 2025 | 460 | 0.400 |
Why?
| Monitoring, Ambulatory | 4 | 2017 | 83 | 0.400 |
Why?
| Appetite Regulation | 3 | 2021 | 26 | 0.380 |
Why?
| Temperature | 1 | 2014 | 628 | 0.370 |
Why?
| Thinness | 1 | 2012 | 89 | 0.370 |
Why?
| Deglutition | 5 | 2014 | 67 | 0.360 |
Why?
| Appetite | 4 | 2022 | 56 | 0.360 |
Why?
| Wearable Electronic Devices | 2 | 2024 | 43 | 0.350 |
Why?
| Heart Rate | 7 | 2025 | 797 | 0.350 |
Why?
| Activities of Daily Living | 4 | 2018 | 381 | 0.340 |
Why?
| Perception | 1 | 2013 | 336 | 0.340 |
Why?
| Melatonin | 5 | 2023 | 120 | 0.330 |
Why?
| Work Schedule Tolerance | 3 | 2020 | 42 | 0.320 |
Why?
| Carbon Dioxide | 2 | 2010 | 258 | 0.320 |
Why?
| Body Weight Maintenance | 2 | 2019 | 16 | 0.310 |
Why?
| Food | 3 | 2024 | 154 | 0.310 |
Why?
| Lipid Peroxidation | 1 | 2009 | 147 | 0.310 |
Why?
| Adaptation, Psychological | 1 | 2013 | 616 | 0.300 |
Why?
| Posture | 5 | 2016 | 176 | 0.300 |
Why?
| Reproducibility of Results | 13 | 2023 | 3009 | 0.300 |
Why?
| Exercise Therapy | 2 | 2025 | 412 | 0.280 |
Why?
| Weight Lifting | 2 | 2009 | 34 | 0.280 |
Why?
| Menopause | 2 | 2022 | 291 | 0.280 |
Why?
| Spectrum Analysis | 3 | 2019 | 86 | 0.280 |
Why?
| Anorexia Nervosa | 2 | 2005 | 80 | 0.270 |
Why?
| Wakefulness | 5 | 2020 | 120 | 0.270 |
Why?
| Cardiovascular Diseases | 3 | 2024 | 1994 | 0.260 |
Why?
| Carbohydrate Metabolism | 3 | 2006 | 60 | 0.260 |
Why?
| Metabolic Syndrome | 1 | 2009 | 338 | 0.250 |
Why?
| Deuterium | 4 | 2021 | 86 | 0.250 |
Why?
| Adolescent | 15 | 2025 | 20158 | 0.250 |
Why?
| Shoes | 5 | 2017 | 18 | 0.250 |
Why?
| Calcium, Dietary | 1 | 2005 | 56 | 0.250 |
Why?
| Physical Endurance | 3 | 2009 | 262 | 0.240 |
Why?
| Mastication | 4 | 2014 | 12 | 0.230 |
Why?
| Gastrointestinal Microbiome | 2 | 2023 | 631 | 0.230 |
Why?
| Sports Equipment | 1 | 2004 | 8 | 0.230 |
Why?
| Eyeglasses | 1 | 2024 | 5 | 0.230 |
Why?
| Double-Blind Method | 3 | 2019 | 1852 | 0.230 |
Why?
| Signal Processing, Computer-Assisted | 3 | 2017 | 144 | 0.220 |
Why?
| Osteoarthritis, Knee | 2 | 2025 | 239 | 0.220 |
Why?
| Cardiorespiratory Fitness | 2 | 2024 | 48 | 0.210 |
Why?
| Physical Fitness | 2 | 2013 | 203 | 0.210 |
Why?
| HIV Integrase | 1 | 2024 | 70 | 0.210 |
Why?
| Biomarkers | 5 | 2024 | 3874 | 0.210 |
Why?
| Motor Activity | 3 | 2019 | 667 | 0.200 |
Why?
| HIV Integrase Inhibitors | 1 | 2024 | 69 | 0.200 |
Why?
| Positron-Emission Tomography | 1 | 2024 | 283 | 0.200 |
Why?
| Puberty | 2 | 2014 | 142 | 0.200 |
Why?
| Insulin Resistance | 4 | 2019 | 1164 | 0.200 |
Why?
| Circadian Clocks | 2 | 2019 | 42 | 0.190 |
Why?
| Bone Density | 2 | 2015 | 474 | 0.190 |
Why?
| Aging | 2 | 2012 | 1745 | 0.190 |
Why?
| Diet, Fat-Restricted | 3 | 2011 | 80 | 0.180 |
Why?
| France | 1 | 2021 | 29 | 0.180 |
Why?
| Feeding Behavior | 4 | 2011 | 618 | 0.180 |
Why?
| Diabetes Mellitus | 1 | 2009 | 994 | 0.180 |
Why?
| Analysis of Variance | 6 | 2021 | 1266 | 0.180 |
Why?
| Bone Remodeling | 1 | 2021 | 71 | 0.180 |
Why?
| Fruit | 1 | 2021 | 131 | 0.180 |
Why?
| Glucose | 2 | 2024 | 983 | 0.170 |
Why?
| Ghrelin | 4 | 2022 | 33 | 0.170 |
Why?
| Vegetables | 1 | 2021 | 147 | 0.170 |
Why?
| Nitrogen | 2 | 2012 | 165 | 0.170 |
Why?
| Cross-Sectional Studies | 6 | 2023 | 5034 | 0.170 |
Why?
| Starch | 1 | 2019 | 22 | 0.160 |
Why?
| Amputees | 1 | 2021 | 80 | 0.160 |
Why?
| Nutritive Value | 1 | 2019 | 36 | 0.160 |
Why?
| Contraceptive Agents | 1 | 2020 | 64 | 0.160 |
Why?
| Sweating | 1 | 2019 | 40 | 0.160 |
Why?
| Aged | 14 | 2025 | 21892 | 0.160 |
Why?
| Inpatients | 1 | 2023 | 464 | 0.160 |
Why?
| Parathyroid Hormone | 1 | 2019 | 106 | 0.160 |
Why?
| Adipocytes | 2 | 2018 | 205 | 0.150 |
Why?
| Body Temperature | 2 | 2010 | 212 | 0.150 |
Why?
| Hospitals | 1 | 2023 | 631 | 0.150 |
Why?
| Telerehabilitation | 1 | 2019 | 36 | 0.150 |
Why?
| Proof of Concept Study | 1 | 2018 | 65 | 0.150 |
Why?
| Adaptation, Physiological | 3 | 2018 | 513 | 0.150 |
Why?
| Postprandial Period | 3 | 2020 | 103 | 0.150 |
Why?
| Guideline Adherence | 1 | 2022 | 523 | 0.140 |
Why?
| High-Intensity Interval Training | 1 | 2018 | 24 | 0.140 |
Why?
| Time-to-Treatment | 1 | 2019 | 178 | 0.140 |
Why?
| Pilot Projects | 5 | 2022 | 1559 | 0.140 |
Why?
| Artificial Limbs | 1 | 2021 | 170 | 0.140 |
Why?
| Postmenopause | 1 | 2019 | 348 | 0.140 |
Why?
| Algorithms | 4 | 2015 | 1609 | 0.140 |
Why?
| Diet, Reducing | 3 | 2025 | 86 | 0.140 |
Why?
| Brain Mapping | 3 | 2016 | 572 | 0.140 |
Why?
| Gait | 2 | 2017 | 277 | 0.140 |
Why?
| Self Report | 1 | 2021 | 796 | 0.130 |
Why?
| Computer Storage Devices | 1 | 2016 | 2 | 0.130 |
Why?
| Tachycardia, Ventricular | 1 | 2018 | 167 | 0.130 |
Why?
| Odds Ratio | 1 | 2019 | 1018 | 0.130 |
Why?
| Combined Modality Therapy | 1 | 2019 | 1199 | 0.130 |
Why?
| Peptide YY | 3 | 2022 | 14 | 0.130 |
Why?
| Homeostasis | 3 | 2019 | 605 | 0.130 |
Why?
| Life Style | 2 | 2021 | 459 | 0.130 |
Why?
| Needs Assessment | 1 | 2018 | 356 | 0.130 |
Why?
| Microbiota | 1 | 2023 | 719 | 0.120 |
Why?
| Estrogens, Conjugated (USP) | 1 | 2015 | 46 | 0.120 |
Why?
| Defibrillators, Implantable | 1 | 2018 | 297 | 0.120 |
Why?
| Metabolomics | 1 | 2020 | 599 | 0.120 |
Why?
| Blood Glucose | 4 | 2020 | 2092 | 0.120 |
Why?
| Sleep Stages | 1 | 2014 | 45 | 0.120 |
Why?
| Skin | 1 | 2019 | 711 | 0.120 |
Why?
| Triglycerides | 2 | 2019 | 523 | 0.110 |
Why?
| Health Status | 1 | 2019 | 747 | 0.110 |
Why?
| Brain | 3 | 2016 | 2615 | 0.110 |
Why?
| Diet Records | 2 | 2014 | 80 | 0.110 |
Why?
| Proteome | 1 | 2018 | 430 | 0.110 |
Why?
| Calcium | 1 | 2019 | 1182 | 0.110 |
Why?
| Task Performance and Analysis | 1 | 2014 | 173 | 0.100 |
Why?
| Muscle Fatigue | 1 | 2014 | 101 | 0.100 |
Why?
| Nervous System Physiological Phenomena | 1 | 2013 | 21 | 0.100 |
Why?
| Surveys and Questionnaires | 3 | 2023 | 5353 | 0.100 |
Why?
| Cell Phone | 1 | 2014 | 70 | 0.100 |
Why?
| Sound Spectrography | 2 | 2009 | 19 | 0.100 |
Why?
| Insulin | 5 | 2020 | 2316 | 0.100 |
Why?
| Urinalysis | 1 | 2012 | 69 | 0.100 |
Why?
| Blood Pressure | 1 | 2019 | 1711 | 0.100 |
Why?
| Hydrogen | 1 | 2012 | 65 | 0.100 |
Why?
| Area Under Curve | 1 | 2013 | 288 | 0.100 |
Why?
| Lasers | 1 | 2012 | 132 | 0.100 |
Why?
| Smoking | 1 | 2019 | 1459 | 0.100 |
Why?
| Adipose Tissue | 3 | 2011 | 589 | 0.100 |
Why?
| Hot Temperature | 2 | 2018 | 359 | 0.100 |
Why?
| Aged, 80 and over | 5 | 2021 | 7029 | 0.090 |
Why?
| Case-Control Studies | 4 | 2021 | 3324 | 0.090 |
Why?
| Veterans | 4 | 2025 | 1397 | 0.090 |
Why?
| Sex Factors | 2 | 2014 | 1942 | 0.090 |
Why?
| Nerve Net | 1 | 2013 | 256 | 0.090 |
Why?
| Prospective Studies | 5 | 2021 | 7035 | 0.090 |
Why?
| Heart Failure | 1 | 2024 | 2141 | 0.090 |
Why?
| Physical Phenomena | 1 | 2010 | 13 | 0.090 |
Why?
| Chronic Disease | 3 | 2024 | 1690 | 0.080 |
Why?
| Muscle Proteins | 1 | 2012 | 221 | 0.080 |
Why?
| Collagen Type I | 2 | 2021 | 117 | 0.080 |
Why?
| Glycerol | 1 | 2009 | 87 | 0.080 |
Why?
| Diet Surveys | 1 | 2009 | 92 | 0.080 |
Why?
| Somatotypes | 1 | 2009 | 3 | 0.080 |
Why?
| Models, Biological | 3 | 2018 | 1689 | 0.080 |
Why?
| Spirometry | 1 | 2010 | 252 | 0.080 |
Why?
| Pattern Recognition, Automated | 1 | 2009 | 72 | 0.080 |
Why?
| Cues | 1 | 2011 | 321 | 0.080 |
Why?
| Thermography | 1 | 2009 | 11 | 0.080 |
Why?
| HIV Infections | 1 | 2024 | 2703 | 0.080 |
Why?
| Validation Studies as Topic | 1 | 2009 | 21 | 0.080 |
Why?
| Nutritional Requirements | 2 | 2024 | 77 | 0.080 |
Why?
| Age Factors | 2 | 2007 | 3100 | 0.080 |
Why?
| Auscultation | 1 | 2008 | 4 | 0.080 |
Why?
| Cerebral Cortex | 1 | 2011 | 422 | 0.070 |
Why?
| Kinetics | 1 | 2012 | 1617 | 0.070 |
Why?
| Healthy Volunteers | 2 | 2019 | 199 | 0.070 |
Why?
| Respiratory Function Tests | 1 | 2010 | 580 | 0.070 |
Why?
| Dietary Supplements | 1 | 2012 | 531 | 0.070 |
Why?
| Colorado | 3 | 2021 | 4369 | 0.070 |
Why?
| Body Fat Distribution | 1 | 2007 | 49 | 0.070 |
Why?
| Phosphorylation | 1 | 2012 | 1681 | 0.070 |
Why?
| Magnetic Resonance Imaging | 3 | 2016 | 3371 | 0.070 |
Why?
| Rats, Wistar | 4 | 2011 | 397 | 0.070 |
Why?
| Sensitivity and Specificity | 3 | 2012 | 1813 | 0.070 |
Why?
| Fatty Acids, Nonesterified | 1 | 2007 | 159 | 0.070 |
Why?
| Reference Values | 2 | 2012 | 776 | 0.070 |
Why?
| Norepinephrine | 1 | 2007 | 209 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2021 | 2428 | 0.070 |
Why?
| Animals | 7 | 2019 | 34487 | 0.060 |
Why?
| Telemedicine | 2 | 2025 | 781 | 0.060 |
Why?
| Patient Selection | 1 | 2009 | 658 | 0.060 |
Why?
| Leptin | 3 | 2014 | 218 | 0.060 |
Why?
| Dairy Products | 1 | 2005 | 36 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2012 | 2508 | 0.060 |
Why?
| Recovery of Function | 2 | 2025 | 630 | 0.060 |
Why?
| Transcription, Genetic | 1 | 2012 | 1403 | 0.060 |
Why?
| Polysomnography | 2 | 2020 | 160 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2022 | 1356 | 0.060 |
Why?
| Photoperiod | 2 | 2019 | 46 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2009 | 997 | 0.060 |
Why?
| Parasympathetic Nervous System | 1 | 2004 | 27 | 0.060 |
Why?
| Shift Work Schedule | 1 | 2024 | 10 | 0.060 |
Why?
| Electrocardiography, Ambulatory | 1 | 2004 | 57 | 0.060 |
Why?
| Equipment Design | 2 | 2017 | 515 | 0.060 |
Why?
| Thrombophilia | 1 | 2024 | 66 | 0.060 |
Why?
| Long QT Syndrome | 1 | 2005 | 67 | 0.050 |
Why?
| Statistics as Topic | 1 | 2004 | 303 | 0.050 |
Why?
| Adiposity | 3 | 2016 | 504 | 0.050 |
Why?
| Walk Test | 1 | 2023 | 70 | 0.050 |
Why?
| Linear Models | 2 | 2018 | 816 | 0.050 |
Why?
| Regression Analysis | 3 | 2018 | 978 | 0.050 |
Why?
| Integrases | 1 | 2024 | 118 | 0.050 |
Why?
| Anaerobic Threshold | 1 | 2002 | 28 | 0.050 |
Why?
| Blood Coagulation | 1 | 2024 | 226 | 0.050 |
Why?
| Sampling Studies | 1 | 2002 | 96 | 0.050 |
Why?
| Sensation | 1 | 2022 | 50 | 0.050 |
Why?
| Hormones | 2 | 2016 | 140 | 0.050 |
Why?
| Electromyography | 2 | 2014 | 380 | 0.050 |
Why?
| Self-Management | 1 | 2024 | 161 | 0.050 |
Why?
| Recurrence | 2 | 2019 | 993 | 0.050 |
Why?
| Satiation | 1 | 2021 | 23 | 0.050 |
Why?
| Women's Health | 1 | 2004 | 361 | 0.050 |
Why?
| Osteocalcin | 1 | 2021 | 36 | 0.050 |
Why?
| Craving | 1 | 2021 | 40 | 0.050 |
Why?
| Patient Reported Outcome Measures | 1 | 2025 | 368 | 0.050 |
Why?
| Perimenopause | 1 | 2022 | 60 | 0.050 |
Why?
| Waist Circumference | 1 | 2021 | 138 | 0.050 |
Why?
| Muscle Strength | 1 | 2024 | 304 | 0.040 |
Why?
| Proteins | 2 | 2006 | 933 | 0.040 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2021 | 112 | 0.040 |
Why?
| Absorptiometry, Photon | 2 | 2016 | 248 | 0.040 |
Why?
| Rats | 4 | 2011 | 5199 | 0.040 |
Why?
| Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| Iodide Peroxidase | 1 | 2019 | 28 | 0.040 |
Why?
| Disability Evaluation | 1 | 2021 | 285 | 0.040 |
Why?
| Bone Resorption | 1 | 2019 | 80 | 0.040 |
Why?
| Health Behavior | 1 | 2024 | 740 | 0.040 |
Why?
| Acidosis | 1 | 2019 | 88 | 0.040 |
Why?
| Mathematical Concepts | 1 | 2018 | 26 | 0.040 |
Why?
| Decision Trees | 1 | 2018 | 90 | 0.040 |
Why?
| Feces | 1 | 2021 | 435 | 0.040 |
Why?
| Patient Discharge | 1 | 2025 | 850 | 0.040 |
Why?
| Methanol | 1 | 2018 | 34 | 0.040 |
Why?
| Single-Blind Method | 1 | 2019 | 267 | 0.040 |
Why?
| Feasibility Studies | 1 | 2022 | 860 | 0.040 |
Why?
| Humidity | 1 | 2018 | 48 | 0.040 |
Why?
| Treatment Outcome | 3 | 2018 | 10110 | 0.040 |
Why?
| Research Design | 1 | 2024 | 1034 | 0.040 |
Why?
| Solvents | 1 | 2018 | 107 | 0.040 |
Why?
| Health Promotion | 1 | 2023 | 716 | 0.030 |
Why?
| Europe | 1 | 2018 | 359 | 0.030 |
Why?
| Lower Extremity | 1 | 2021 | 401 | 0.030 |
Why?
| Wrist | 1 | 2017 | 53 | 0.030 |
Why?
| Sex Characteristics | 1 | 2002 | 719 | 0.030 |
Why?
| Plasma | 1 | 2018 | 199 | 0.030 |
Why?
| Methods | 1 | 1996 | 64 | 0.030 |
Why?
| Materials Testing | 1 | 2018 | 344 | 0.030 |
Why?
| Maximal Voluntary Ventilation | 1 | 2016 | 8 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2021 | 1934 | 0.030 |
Why?
| Self Disclosure | 1 | 1996 | 62 | 0.030 |
Why?
| Equipment and Supplies | 1 | 1996 | 41 | 0.030 |
Why?
| Proteomics | 1 | 2022 | 1008 | 0.030 |
Why?
| Carbon Isotopes | 1 | 1996 | 123 | 0.030 |
Why?
| Smartphone | 1 | 2016 | 88 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2016 | 356 | 0.030 |
Why?
| Disease Models, Animal | 3 | 2011 | 3936 | 0.030 |
Why?
| Nontherapeutic Human Experimentation | 1 | 2014 | 4 | 0.030 |
Why?
| Child | 3 | 2024 | 20636 | 0.030 |
Why?
| Peptides | 1 | 2019 | 910 | 0.030 |
Why?
| Support Vector Machine | 1 | 2014 | 36 | 0.030 |
Why?
| Risk Factors | 2 | 2020 | 9696 | 0.030 |
Why?
| Machine Learning | 1 | 2018 | 442 | 0.030 |
Why?
| Retrospective Studies | 2 | 2023 | 14404 | 0.030 |
Why?
| Logistic Models | 1 | 2018 | 1975 | 0.030 |
Why?
| Interviews as Topic | 1 | 1996 | 714 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2015 | 1012 | 0.020 |
Why?
| Bicycling | 1 | 2013 | 116 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2015 | 248 | 0.020 |
Why?
| Anabolic Agents | 1 | 2012 | 12 | 0.020 |
Why?
| United States | 2 | 2020 | 13785 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2019 | 1421 | 0.020 |
Why?
| RNA, Messenger | 1 | 2019 | 2669 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2016 | 734 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 1943 | 0.020 |
Why?
| Oxygen | 1 | 2016 | 899 | 0.020 |
Why?
| Muscle Contraction | 1 | 2014 | 423 | 0.020 |
Why?
| Biomechanical Phenomena | 1 | 2014 | 758 | 0.020 |
Why?
| Transcription Factors | 1 | 2019 | 1628 | 0.020 |
Why?
| Photic Stimulation | 1 | 2011 | 239 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2018 | 2706 | 0.020 |
Why?
| Geriatric Assessment | 1 | 2012 | 205 | 0.020 |
Why?
| Models, Theoretical | 1 | 2014 | 541 | 0.020 |
Why?
| Fourier Analysis | 1 | 2009 | 39 | 0.020 |
Why?
| Hydrostatic Pressure | 1 | 2009 | 18 | 0.020 |
Why?
| Cognition | 1 | 2016 | 1104 | 0.020 |
Why?
| Electric Impedance | 1 | 2009 | 101 | 0.020 |
Why?
| Body Height | 1 | 2009 | 192 | 0.020 |
Why?
| Arrhythmias, Cardiac | 1 | 2005 | 314 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 185 | 0.010 |
Why?
| Mice | 1 | 2019 | 16574 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2005 | 2703 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|